Am J Perinatol 2022; 29(14): 1489-1495
DOI: 10.1055/a-1877-5880
SMFM Fellowship Series Article

Perceptions and Attitudes toward COVID-19 Vaccination among Pregnant and Postpartum Individuals

1   Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts
2   Harvard Medical School, Boston, Massachusetts
,
3   Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts
,
Kaitlyn James
1   Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts
2   Harvard Medical School, Boston, Massachusetts
,
Brandon R. McBay
4   Department of Social and Behavioral Sciences, Harvard TH Chan School of Public Health, Boston, Massachusetts
,
2   Harvard Medical School, Boston, Massachusetts
5   Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts
,
Julianna Schantz-Dunn
2   Harvard Medical School, Boston, Massachusetts
5   Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts
,
Khady Diouf*
2   Harvard Medical School, Boston, Massachusetts
5   Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts
,
Ilona T. Goldfarb*
1   Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts
2   Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Funding K.J.G. has consulted for Illumina Inc., Aetion, and BillionToOne outside the scope of the submitted work. No other financial disclosures are reported by the authors of this paper.

Abstract

Objective This study aimed to characterize attitudes toward novel coronavirus disease 2019 (COVID-19) vaccination and to evaluate factors associated with vaccine uptake among pregnant individuals.

Study Design An anonymous survey was distributed to a convenience sample of pregnant individuals receiving prenatal care at two large urban academic hospitals in a single health care network in Massachusetts. Individual demographic variables were included in the survey along with questions assessing attitudes toward COVID-19 and vaccination in pregnancy. Data were analyzed using parametric or nonparametric tests when appropriate, and associated odds ratios (OR) were calculated via univariable logistic regression.

Results There were 684 surveys distributed, and 477 pregnant and postpartum individuals completed the survey, for a response rate of 69.7%. Overall, 233 (49.3%) had received or were scheduled to receive a COVID-19 vaccine. Age, White race, non-Hispanic or Latinx ethnicity, working from home, and typical receipt of the influenza vaccine were associated with COVID-19 vaccination. Further, 276 respondents (58.4%) reported that their provider recommended the COVID-19 vaccine in pregnancy; these participants were more likely to have received a vaccine (OR = 5.82, 95% confidence interval [CI]: 3.68–9.26, p < 0.005). Vaccinated individuals were less likely to be worried about the effects of the vaccine on themselves (OR = 0.18, 95% CI: 0.12–0.27, p < 0.005) or their developing babies (OR = 0.17, 95% CI: 0.11–0.26, p < 0.005). Unvaccinated individuals were less likely to report that it is easy to schedule a COVID-19 vaccine (OR = 0.56, 95% CI: 0.34–0.93, p = 0.02), to travel to receive a vaccine (OR = 0.19, 95% CI: 0.10–0.36, p < 0.005), and to miss work to receive a vaccine (OR = 0.30, 95% CI: 0.18–0.48, p < 0.005).

Conclusion Strategies are needed to improve patient education regarding vaccine side effects and safety in pregnancy. Policy changes should focus on making it feasible for patients to schedule a vaccine and miss work without loss of pay to get vaccinated.

Key Points

  • There were racial and ethnic disparities in COVID-19 vaccination.

  • Unvaccinated respondents were more likely to be concerned about vaccine effects for themselves or their growing babies.

  • Unvaccinated respondents cited work and scheduling-related barriers to vaccination, indicating areas for advocacy.

* Both Drs. Diouf and Goldfarb have contributed to this project to meet the role of senior author.


Supplementary Material



Publication History

Received: 02 November 2021

Accepted: 03 June 2022

Accepted Manuscript online:
16 June 2022

Article published online:
10 July 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Ellington S, Strid P, Tong VT. et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (25) 769-775
  • 2 Zambrano LD, Ellington S, Strid P. et al; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (44) 1641-1647
  • 3 Yap M, Debenham L, Kew T. et al; PregCOV-19 Consortium. Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol. BMJ Open 2020; 10 (12) e041868
  • 4 Centers for Disease Control and Prevention. COVID Data Tracker. Accessed June 28, 2022 at: https://covid.cdc.gov/covid-data-tracker/#pregnant-population
  • 5 Woodworth KR, Olsen EO, Neelam V. et al; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT). Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (44) 1635-1640
  • 6 Rajewska A, Mikołajek-Bedner W, Lebdowicz-Knul J, Sokołowska M, Kwiatkowski S, Torbé A. COVID-19 and pregnancy - where are we now? A review. J Perinat Med 2020; 48 (05) 428-434
  • 7 Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021; 193 (16) E540-E548
  • 8 Narang K, Enninga EAL, Gunaratne MDSK. et al. SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clin Proc 2020; 95 (08) 1750-1765
  • 9 Di Mascio D, Sen C, Saccone G. et al. Risk factors associated with adverse fetal outcomes in pregnancies affected by coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. J Perinat Med 2020; 48 (09) 950-958
  • 10 Di Mascio D, Khalil A, Saccone G. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2 (02) 100107
  • 11 Beigi RH, Krubiner C, Jamieson DJ. et al. The need for inclusion of pregnant women in COVID-19 vaccine trials. Vaccine 2021; 39 (06) 868-870
  • 12 Maykin MM, Heuser C, Feltovich H. with the Society for Maternal-Fetal Medicine Health Policy Advocacy Committee. Pregnant people deserve the protection offered by SARS-CoV-2 vaccines. Vaccine 2021; 39 (02) 171-172
  • 13 Shimabukuro TT, Kim SY, Myers TR. et al; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med 2021; 384 (24) 2273-2282
  • 14 Zauche LH, Wallace B, Smoots AN. et al. Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020–21. Res Sq. 2021 (e-pub ahead of print). DOI: 10.21203/rs.3.rs-798175/v1
  • 15 Goldshtein I, Nevo D, Steinberg DM. et al. Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women. JAMA 2021; 326 (08) 728-735
  • 16 Gray KJ, Bordt EA, Atyeo C. et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021; 225 (03) 303.e1-303.e17
  • 17 Statistics CfDC-NCfH. COVID-19 vaccines while pregnant or breastfeeding. Accessed June 28, 2022 at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
  • 18 Society for Maternal Fetal Medicine: Provider considerations for engaging in covid-10 vaccine counseling with pregnant and lactating patients. Accessed June 28, 2022 at: https://s3.amazonaws.com/cdn.smfm.org/media/3070/Provider_Considerations_for_Engaging_in_COVID_Vaccination_Considerations_8-13-21_%28final%29__.pdf
  • 19 ACOG Immunization ID, and Public Health Preparedness Expert Work Group. COVID-19 vaccination considerations for obstetric-gynecologic care. Accessed June 28, 2022 at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care
  • 20 Razzaghi H, Meghani M, Pingali C. et al. COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (24) 895-899
  • 21 Razzaghi HKhan KE, Black CL. et al. Influenza and Tdap vaccination coverage among pregnant women—United States, April 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (39) 1391-1397
  • 22 Allotey J, Stallings E, Bonet M. et al; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370: m3320
  • 23 Goncu Ayhan S, Oluklu D, Atalay A. et al. COVID-19 vaccine acceptance in pregnant women. Int J Gynaecol Obstet 2021; 154 (02) 291-296
  • 24 Skjefte M, Ngirbabul M, Akeju O. et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 2021; 36 (02) 197-211
  • 25 Sutton D, D'Alton M, Zhang Y. et al. COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women. Am J Obstet Gynecol MFM 2021; 3 (05) 100403
  • 26 Mass.gov. Massachusetts COVID-19 vaccination data and updates. Accessed June 28, 2022 at: https://www.mass.gov/info-details/massachusetts-covid-19-vaccination-data-and-updates#daily-covid-19-vaccine-report-
  • 27 Turocy JRA, Reshef E, D'Alton M, Forman E, Williams Z. A survey of fertility patients' attitudes towards the COVID-19 vaccine. Accessed June 28, 2022 at: https://www.fertstertdialog.com/posts/a-survey-of-fertility-patients-attitudes-towards-the-covid-19-vaccine
  • 28 Van Buynder PG, Van Buynder JL, Menton L, Thompson G, Sun J. Antigen specific vaccine hesitancy in pregnancy. Vaccine 2019; 37 (21) 2814-2820
  • 29 Battarbee AN, Stockwell MS, Varner M. et al. Attitudes toward COVID-19 illness and COVID-19 vaccination among pregnant women: a cross-sectional multicenter study during August-December 2020. Am J Perinatol 2022; 39 (01) 75-83
  • 30 Corbie-Smith G. Vaccine hesitancy is a scapegoat for structural racism. JAMA Health Forum 2021; 2 (03) e210434
  • 31 Garg I, Shekhar R, Sheikh AB, Pal S. COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines. Infect Dis Rep 2021; 13 (03) 685-699
  • 32 Stafford IA, Parchem JG, Sibai BM. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. Am J Obstet Gynecol 2021; 224 (05) 484-495
  • 33 Coley KC, Gessler C, McGivney M, Richardson R, DeJames J, Berenbrok LA. Increasing adult vaccinations at a regional supermarket chain pharmacy: a multi-site demonstration project. Vaccine 2020; 38 (24) 4044-4049
  • 34 Zhai Y, Santibanez TA, Kahn KE, Black CL, de Perio MA. Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers. Vaccine 2018; 36 (48) 7316-7323
  • 35 Gessler CA, Richardson RM, Hall DL, Coley KC. Operationalizing pandemic vaccinations at a regional supermarket chain pharmacy. Disaster Med Public Health Prep 2021; (e-pub ahead of print). DOI: 10.1017/dmp.2021.43.
  • 36 Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine 2016; 34 (52) 6700-6706
  • 37 Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine 2015; 33 (47) 6420-6429